{
  "primary": "ATXN3",
  "interaction_type": "indirect",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 deubiquitinates and stabilizes the cell cycle phosphatase Cdc25A, a key regulator of cell cycle progression.",
  "functions": [
    {
      "function": "Indirect Cdc25A Destabilization via Chk1",
      "arrow": "activates",
      "cellular_process": "ATXN3 indirectly promotes the degradation of the cell cycle phosphatase Cdc25A by stabilizing its upstream kinase, Chk1.",
      "effect_description": "ATXN3 deubiquitinates and stabilizes the checkpoint kinase Chk1. Activated Chk1 then phosphorylates Cdc25A during the S phase of the cell cycle. This phosphorylation event serves as a signal for ubiquitin ligases to polyubiquitinate Cdc25A, leading to its rapid degradation by the proteasome. The resulting decrease in Cdc25A levels prevents the activation of cyclin-dependent kinases (CDKs), thereby inhibiting origin firing and halting cell cycle progression to allow for DNA repair.",
      "biological_consequence": [
        "ATXN3 binds and deubiquitinates Chk1 → Chk1 protein is stabilized and protected from proteasomal degradation → Active Chk1 phosphorylates Cdc25A phosphatase → Phosphorylated Cdc25A is recognized by E3 ubiquitin ligases and degraded → CDK activity is suppressed → Cell cycle progression is inhibited"
      ],
      "specific_effects": [
        "Indirectly promotes proteasomal degradation of Cdc25A.",
        "Contributes to the S-phase checkpoint control by reducing Cdc25A levels."
      ],
      "evidence": [
        {
          "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
          "journal": "Expert Reviews in Molecular Medicine",
          "year": 2024,
          "relevant_quote": "Interestingly, ATXN3 regulates Chk1, a central kinase in the DDR. Chk1 is activated by different types of DNA lesions and replication stress, delaying cell cycle progression to facilitate DNA repair. During S phase, activated Chk1 phosphorylates Cdc25A phosphatase, inducing its degradation, thereby inhibiting origin firing and replication fork progression.",
          "pmid": "39320846"
        }
      ],
      "pathway": {
        "name": "Cell Cycle Regulation",
        "canonical_name": "Cell Cycle Regulation",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "39320846"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "main_to_primary",
      "function_effect": "activation",
      "arrow_context": {
        "direct_from": null,
        "direct_arrow": "activates",
        "net_from": "ATXN3",
        "net_arrow": "activates",
        "mediator_chain": [],
        "is_indirect": true
      },
      "net_arrow": "activates",
      "direct_arrow": "activates",
      "net_effect": "activation",
      "direct_effect": "activation"
    }
  ],
  "arrow": "inhibits",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input claim that ATXN3 directly deubiquitinates and STABILIZES Cdc25A is INVALID. The literature reveals an opposing, indirect mechanism. ATXN3 stabilizes the kinase Chk1, which in turn phosphorylates Cdc25A, marking it for proteasomal degradation. Therefore, the net effect of ATXN3's activity on this pathway is the INHIBITION of Cdc25A.",
  "mechanism": "ATXN3 indirectly promotes the degradation of the cell cycle phosphatase Cdc25A by stabilizing its upstream kinase, Chk1.",
  "effect": "ATXN3 deubiquitinates and stabilizes the checkpoint kinase Chk1. Activated Chk1 then phosphorylates Cdc25A during the S phase of the cell cycle. This phosphorylation event serves as a signal for ubiquitin ligases to polyubiquitinate Cdc25A, leading to its rapid degradation by the proteasome. The resulting decrease in Cdc25A levels prevents the activation of cyclin-dependent kinases (CDKs), thereby inhibiting origin firing and halting cell cycle progression to allow for DNA repair.",
  "summary": "ATXN3 inhibits Cdc25A to modulate indirect cdc25a destabilization via chk1, ultimately affecting cell cycle progression is inhibited.",
  "evidence": [
    {
      "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
      "journal": "Expert Reviews in Molecular Medicine",
      "year": 2024,
      "relevant_quote": "Interestingly, ATXN3 regulates Chk1, a central kinase in the DDR. Chk1 is activated by different types of DNA lesions and replication stress, delaying cell cycle progression to facilitate DNA repair. During S phase, activated Chk1 phosphorylates Cdc25A phosphatase, inducing its degradation, thereby inhibiting origin firing and replication fork progression."
    }
  ],
  "pathways": [
    {
      "name": "Cell Cycle Regulation",
      "canonical_name": "Cell Cycle Regulation",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 2
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --inhibits--> Cdc25A:",
  "protein_a": "Cdc25A",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-08T02:27:47.363461Z",
  "last_updated": "2025-12-08T02:27:47.363461Z"
}